Drug Shortage Report for KETAMINE HYDROCHLORIDE INJECTION USP
Report ID | 204614 |
Drug Identification Number | 02246796 |
Brand name | KETAMINE HYDROCHLORIDE INJECTION USP |
Common or Proper name | KETAMINE HCL |
Company Name | SANDOZ CANADA INCORPORATED |
Market Status | MARKETED |
Active Ingredient(s) | KETAMINE |
Strength(s) | 50MG |
Dosage form(s) | SOLUTION |
Route of administration | INTRAVENOUS INTRAMUSCULAR INTRAVENOUS INTRAMUSCULAR |
Packaging size | 10ML 1LIVI |
ATC code | N01AX |
ATC description | ANESTHETICS, GENERAL |
Reason for shortage | Requirements related to complying with good manufacturing practices. |
Anticipated start date | 2023-11-20 |
Actual start date | |
Estimated end date | 2023-12-18 |
Actual end date | 2023-11-22 |
Shortage status | Resolved |
Updated date | 2023-11-23 |
Company comments | Product is available on allocation at wholesalers, based on 100% of historical volumes. |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 110 RUE DE LAUZON BOUCHERVILLE, QUEBEC CANADA J4B 1E6 |
Company contact information | 1 800-361-3062 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v6 | 2023-11-23 | English | Compare |
v5 | 2023-11-22 | French | Compare |
v4 | 2023-11-22 | English | Compare |
v3 | 2023-11-21 | English | Compare |
v2 | 2023-09-18 | French | Compare |
v1 | 2023-09-18 | English | Compare |
Showing 1 to 6 of 6